Literature DB >> 12748652

Osteoclast differentiation and activation.

William J Boyle1, W Scott Simonet, David L Lacey.   

Abstract

Osteoclasts are specialized cells derived from the monocyte/macrophage haematopoietic lineage that develop and adhere to bone matrix, then secrete acid and lytic enzymes that degrade it in a specialized, extracellular compartment. Discovery of the RANK signalling pathway in the osteoclast has provided insight into the mechanisms of osteoclastogenesis and activation of bone resorption, and how hormonal signals impact bone structure and mass. Further study of this pathway is providing the molecular basis for developing therapeutics to treat osteoporosis and other diseases of bone loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748652     DOI: 10.1038/nature01658

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1841 in total

1.  Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model.

Authors:  Bethany A Kerr; Ranko Miocinovic; Armine K Smith; Eric A Klein; Tatiana V Byzova
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice.

Authors:  Ganesh V Halade; Amina El Jamali; Paul J Williams; Roberto J Fajardo; Gabriel Fernandes
Journal:  Exp Gerontol       Date:  2010-10-12       Impact factor: 4.032

3.  Anti-inflammatory activities of light emitting diode irradiation on collagen-induced arthritis in mice (a secondary publication).

Authors:  Noboru Kuboyama; Mitsuhiro Ohta; Yusuke Sato; Yoshimitsu Abiko
Journal:  Laser Ther       Date:  2014-09-30

4.  Molecular mechanisms of the biphasic effects of interferon-γ on osteoclastogenesis.

Authors:  Jing Cheng; Jianzhong Liu; Zhenqi Shi; Joel Jules; Duorong Xu; Shaokai Luo; Shi Wei; Xu Feng
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

5.  Changes in proximal femur bone properties following ovariectomy and their association with resistance to fracture.

Authors:  Hélder Fonseca; Daniel Moreira-Gonçalves; Mário Vaz; Maria Helena Fernandes; Rita Ferreira; Francisco Amado; Maria Paula Mota; José Alberto Duarte
Journal:  J Bone Miner Metab       Date:  2011-09-21       Impact factor: 2.626

6.  Osteoblasts Are Rapidly Ablated by Virus-Induced Systemic Inflammation following Lymphocytic Choriomeningitis Virus or Pneumonia Virus of Mice Infection in Mice.

Authors:  Steven Maltby; Alyssa J Lochrin; Bianca Bartlett; Hock L Tay; Jessica Weaver; Ingrid J Poulton; Maximilian W Plank; Helene F Rosenberg; Natalie A Sims; Paul S Foster
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

Review 7.  Myeloma and Bone Disease.

Authors:  Cristina Panaroni; Andrew J Yee; Noopur S Raje
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

8.  BIX01294 suppresses osteoclast differentiation on mouse macrophage-like Raw264.7 cells.

Authors:  Hiromasa Tsuda; Ning Zhao; Kenichi Imai; Kuniyasu Ochiai; Pishan Yang; Naoto Suzuki
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

Review 9.  Denosumab: anti-RANKL antibody.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

10.  Influence of receptor activator of nuclear factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity.

Authors:  Ludwika Kreja; Astrid Liedert; Carla Schmidt; Lutz Claes; Anita Ignatius
Journal:  J Mol Histol       Date:  2007-06-19       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.